Most Recent
IP Australia stubs out Philip Morris opposition to British American Tobacco e-cig trade mark
Intellectual Property 2019-07-24 8:39 pm By Miklos Bolza

US tobacco giant Philip Morris has failed in its challenge before IP Australia to rival British American Tobacco’s application for a trade mark to be used on its electronic cigarettes.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Monster Energy takes another shot at blocking monster wheels trade mark
Intellectual Property 2019-07-17 4:28 pm By Cat Fredenburgh

Beverage giant Monster Energy has appealed a ruling that allowed a company associated with leading tyre retailer Bob Jane T-Mart to register trade marks for its Monster brand alloy wheels.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme loses key battle in trade mark case ahead of trial
Intellectual Property 2019-07-15 8:51 pm By Miklos Bolza

A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed by German law, settling a key question before a trade mark case between the two drug giants goes to trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ariosa infringed Sequenom’s patent for prenatal genetic test, court finds
Intellectual Property 2019-07-01 10:07 pm By Cat Fredenburgh

A court has found Ariosa Diagnostics infringed a patent held by Sequenom for a noninvasive prenatal genetic test, and ruled one claim of the patent invalid for lack of fair basis.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge crushes Monster Energy’s opposition to monster wheel trade marks
Intellectual Property 2019-06-21 10:05 pm By Cat Fredenburgh

A judge has allowed a company associated with leading tyre retailer Bob Jane T-Mart to register three trade marks for its brand of Monster alloy wheels, dismissing claims from US energy drink giant Monster Energy that allowing the registration would lead to confusion.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Grand Theft Auto modder confident of defence in Take-Two copyright case
Intellectual Property 2019-06-21 1:11 pm By Miklos Bolza

A developer of what’s now being called the “Infamous Mod” for video game Grand Theft Auto, which gives players extra powers, is confident he can defend the copyright case brought against him by Take-Two Interactive and its subsidiary Rockstar Games.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis patent for oral form of top-selling MS drug obvious, IP Australia says
Intellectual Property 2019-05-13 12:31 pm By Miklos Bolza

A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen, Alphapharm lay down swords in long-running battle over HIV drug patent
Intellectual Property 2019-05-06 12:03 pm By Cat Fredenburgh

Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

B. Braun drops appeal after IV catheter patents invalidated
Intellectual Property 2019-04-29 9:12 pm By Cat Fredenburgh

German medical device company B. Braun Melsungen has dropped its appeal of a ruling invalidating three of its intravenous catheter patents and finding rival Becton Dickinson did not infringe the patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Generic drug maker Juno can’t withdraw admission ahead of trial over Velcade patent
Intellectual Property 2019-04-24 1:32 pm By Christine Caulfield

A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?